Anne Kirkpatrick

6.0k total citations · 2 hit papers
16 papers, 4.4k citations indexed

About

Anne Kirkpatrick is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Anne Kirkpatrick has authored 16 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 3 papers in Surgery. Recurrent topics in Anne Kirkpatrick's work include Sarcoma Diagnosis and Treatment (5 papers), Lung Cancer Research Studies (5 papers) and Vascular Tumors and Angiosarcomas (4 papers). Anne Kirkpatrick is often cited by papers focused on Sarcoma Diagnosis and Treatment (5 papers), Lung Cancer Research Studies (5 papers) and Vascular Tumors and Angiosarcomas (4 papers). Anne Kirkpatrick collaborates with scholars based in Netherlands, Belgium and United Kingdom. Anne Kirkpatrick's co-authors include M. van Glabbeke, M. Bolla, J. Giralt, Jean Bourhis, Frédéric Rolland, Katarzyna Łukawska‐Matuszewska, Jacques Bernier, C. Domenge, Jean-Louis Lefèbvre and P. Maingon and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Anne Kirkpatrick

16 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer

2004 2.2k citations Jacques Bernier, C. Domenge et al. New England Journal of Medicine profile →
Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1992 998 citations C. Schaake-Koning, Walter Van den Bogaert et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Anne Kirkpatrick

Since Specialization

Citations

This map shows the geographic impact of Anne Kirkpatrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Kirkpatrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Kirkpatrick more than expected).

Fields of papers citing papers by Anne Kirkpatrick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Kirkpatrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Kirkpatrick. The network helps show where Anne Kirkpatrick may publish in the future.

Co-authorship network of co-authors of Anne Kirkpatrick

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Kirkpatrick. A scholar is included among the top collaborators of Anne Kirkpatrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Kirkpatrick. Anne Kirkpatrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Phase III Trial of Two Investigational Schedules of Ifosfamide Compared With Standard-Dose Doxorubicin in Advanced or Metastatic Soft Tissue Sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study 2007 ·Journal of Clinical Oncology ·Paul Lorigan, Jaap Verweij, Zsuzsa Pápai, Sjoerd Rodenhuis, Axel Le Cesne, Michael Leahy, John Radford, M. M. Van Glabbeke, Anne Kirkpatrick, Pancras C.W. Hogendoorn, Jean‐Yves Blay	192
2	Improvement in Histologic Response But Not Survival in Osteosarcoma Patients Treated With Intensified Chemotherapy: A Randomized Phase III Trial of the European Osteosarcoma Intergroup 2007 ·JNCI Journal of the National Cancer Institute ·Ian Lewis, M. Nooij, Jeremy Whelan, Matthew R. Sydes, R. J. Grimer, Pancras C.W. Hogendoorn, Muhammad Ali Memon, Simon Weeden, Barbara Uscinska, M. van Glabbeke, Anne Kirkpatrick, Esther Hauben, Alan Craft, Antonïe H.M. Taminiau	272
3	Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer breakdown → 2004 ·New England Journal of Medicine ·Jacques Bernier, C. Domenge, Mahmut Özsahin, Katarzyna Łukawska‐Matuszewska, Jean-Louis Lefèbvre, Richard Greiner, J. Giralt, P. Maingon, Frédéric Rolland, M. Bolla, F. Cognetti, Jean Bourhis, Anne Kirkpatrick, M. van Glabbeke	2209
4	Epirubicin is not Superior to Doxorubicin in the Treatment of Advanced Soft Tissue Sarcomas. The Experience of the EORTC Soft Tissue and Bone Sarcoma Group 2000 ·Sarcoma ·Ole S. Nielsen, P Dombernowsky, Henning T. Mouridsen, Søren Daugaard, M. van Glabbeke, Anne Kirkpatrick, Jaap Verweij	27
5	Treatment of Brain Metastases of Small-Cell Lung Cancer: Comparing Teniposide and Teniposide With Whole-Brain Radiotherapy—A Phase III Study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group 2000 ·Journal of Clinical Oncology ·Pieter E. Postmus, Hanny Haaxma-Reiche, Egbert F. Smit, Harry J.M. Groen, (unknown), (unknown), Jan P. van Meerbeeck, Mario Clerico, Anna Gregor, Desmond Curran, Tarek Sahmoud, Anne Kirkpatrick, Giuseppe Giaccone	165
6	Neoadjuvant Chemotherapy With Doxorubicin and Cisplatin in Malignant Fibrous Histiocytoma of Bone: A European Osteosarcoma Intergroup Study 1999 ·Journal of Clinical Oncology ·Vivien Bramwell, William P. Steward, M. Nooij, Jeremy Whelan, Alan Craft, R. J. Grimer, (unknown), S.R. Cannon, Archie J. Malcolm, Pancras C.W. Hogendoorn, Barbara Uscinska, Anne Kirkpatrick, David Machin, M. M. Van Glabbeke	57
7	Brain-only metastases of small cell lung cancer; efficacy of whole brain radiotherapy. An EORTC phase II study 1998 ·Radiotherapy and Oncology ·Pieter E. Postmus, Hanny Haaxma-Reiche, Anna Gregor, Harry J.M. Groen, (unknown), (unknown), Anne Kirkpatrick, Desmond Curran, Tarek Sahmoud, Giuseppe Giaccone	68
8	Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup 1997 ·The Lancet ·Robert L. Souhami, Alan Craft, Jan W. van der Eijken, M. Nooij, D. Spooner, Vivien Bramwell, Rafal Wierzbicki, (unknown), Anne Kirkpatrick, Barbara Uscinska, M. van Glabbeke, David Machin	279
9	Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: A phase II study of the EORTC lung cancer cooperative group 1993 ·European Journal of Cancer ·Pieter E. Postmus, Egbert F. Smit, Anne Kirkpatrick, Ted A.W. Splinter	26
10	Epirubicin in previously untreated patients with small cell lung cancer: A phase II study by the EORTC lung cancer cooperative group 1992 ·European Journal of Cancer ·Élisabeth Quoix, Giuseppe Giaccone, Jacek Jassem, (unknown), (unknown), H. Cortés-Funes, K. J. Roozendaal, Anne Kirkpatrick, (unknown), Nico van Zandwijk	13
11	Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer breakdown → 1992 ·New England Journal of Medicine ·C. Schaake-Koning, Walter Van den Bogaert, Otilia Dalesio, Jan Festen, Jaap Hoogenhout, Paul Van Houtte, Anne Kirkpatrick, Mia G.J. Koolen, B. Maat, (unknown), A. Renaud, Patrick Rodrigus, (unknown), Jean‐Paul Sculier, Nico van Zandwijk, Harry Bartelink	998
12	Mitoxantrone in malignant pleural mesothelioma: A study by the EORTC lung cancer cooperative group 1991 ·European Journal of Cancer and Clinical Oncology ·(unknown), K. Mattson, Giuseppe Giaccone, Nico van Zandwijk, H. T. Planteydt, Anne Kirkpatrick, Otilia Dalesio	41
13	The need for immediate monitoring of treatment parameters and uniform assessment of patient data in clinical trials 1991 ·European Journal of Cancer and Clinical Oncology ·C. Schaake-Koning, Anne Kirkpatrick, Robert Kröger, Nico van Zandwijk, Harry Bartelink	23
14	Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung 1989 ·European Journal of Cancer and Clinical Oncology ·Gerald G. Anderson, (unknown), John Smyth, Giuseppe Giaccone, (unknown), André Planting, Otilia Dalesio, Anne Kirkpatrick, Gordon McVie	8
15	Phase II study of a combination of hydroxyurea, fluorouracil and mitomycin in previously treated squamous cell carcinoma of the head and neck 1986 ·European Journal of Cancer and Clinical Oncology ·P. Dodion, (unknown), (unknown), O. Dalesio, Anne Kirkpatrick, Marcel Rozencweig	9
16	Combination chemotherapy with cisplatin, methotrexate, bleomycin, and vincristine (CABO) in advanced squamous cell carcinoma of the head and neck 1984 ·Cancer ·Marcel Rozencweig, P. Dodion, U. Bruntsch, W. M. Gallmeier, (unknown), (unknown), (unknown), (unknown), Anne Kirkpatrick, (unknown), (unknown), (unknown)	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact